BSE filing, NSE: GODREJIND. Summary written from the filing by ALFA Finder's alert engine.
Godrej Industries Ltd: key numbers
- Share price
- ₹942.90
- Market cap
- ₹31,762 Cr
- Revenue (annual)
- ₹22,237 Cr
- Net profit (annual)
- ₹1,241 Cr
- P/E (TTM)
- 27.0×Sector 21.7×
- Promoter holding
- 74.63%-0.01% QoQ
- FII holding
- 4.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godrej Industries Ltd
All →Godrej Industries Debt & Borrowing: ₹75 Cr
Godrej Industries Limited has redeemed Commercial Papers worth ₹75 Crore on their maturity date. The redemption of ISIN INE233A149M1 confirms fulfillment of payment obligations.
- Value
- ₹75.00 Cr
Godrej Industries Price Movement Clarification
Godrej Industries Limited clarified that it has disclosed all price-sensitive information to exchanges. The filing responds to a BSE query regarding significant volume movement in its shares.
Godrej Industries Credit Rating
Godrej Industries received credit ratings from CRISIL for its NCD and Commercial Paper programmes, with reaffirmations for existing instruments and a new assignment for proposed NCDs.
Godrej Industries Debt & Borrowing: ₹2,775 Cr
Godrej Industries Limited certified the utilization of proceeds from 38 Commercial Paper issuances totaling Rs. 2,775 Crore. The funds were used for purposes disclosed in offer letters.
- Value
- ₹2,775 Cr
Godrej Industries Annual General Meeting
Godrej Industries reported the results of its Postal Ballot, confirming the appointment and remuneration of Nirojsha Godrej as Executive Chairperson for a five-year term.
Godrej Industries Acquisition Worth ₹335 Cr
Godrej Industries Limited has invested approximately ₹335 Crore in its wholly owned subsidiary, Godrej Investment Limited. The transaction maintains the entity's status as a 100% subsidiary.
- Value
- ₹335.0 Cr
- Execution
- Completed
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.